Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 225

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Human placenta: a human organ for developmental toxicology research and biomonitoring

Myllynen, P., Pasanen, M., Pelkonen, O.·2005·Placenta
DOI 10.1016/j.placenta.2004.09.006
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.placenta.2004.09.006

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 144

  1. Clarke, 1985, Differential pharmacokinetics for oral and intraperitoneal administration of ethanol to the pregnant guinea pig, Can J Physiol Pharmacol, 63, 169, 10.1139/y85-033 · DOI
  2. Faber, 1992, Physiology of placental transfer in mammals, Am Zool, 32, 343, 10.1093/icb/32.2.343 · DOI
  3. Leiser, 1994, Placental structure: in a comparative aspect, Exp Clin Endocrinol, 102, 122, 10.1055/s-0029-1211275 · DOI
  4. Mossman, 1937, Comparative morphogenesis of the fetal membranes and accessory uterine structures, Carnegie Inst Washington Publ 479, Contrib Embryol, 26, 129
  5. Enders, 1999, Comparative placental structure, Adv Drug Deliv Rev, 38, 3, 10.1016/S0169-409X(99)00003-4 · DOI
  6. Panigel, 1986, The human placenta. Anatomy and morphology, Clin Obstet Gynecol, 13, 421
  7. Boyd, 1967, Development and structure of the human placenta from the end of the 3rd month of gestation, J Obstet Gynaecol Br Commonw, 74, 161, 10.1111/j.1471-0528.1967.tb14864.x · DOI
  8. Falcon, 2002, Environmental exposures to lead and cadmium measured in human placenta, Arch Environ Health, 57, 598, 10.1080/00039890209602094 · DOI
  9. Kantola, 2000, Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg, Environ Res, 83, 54, 10.1006/enrs.1999.4043 · DOI
  10. Reichrtova, 1998, Sites of lead and nickel accumulation in the placental tissue, Hum Exp Toxicol, 17, 176, 10.1177/096032719801700309 · DOI
  11. Baranowska, 1995, Lead and cadmium in human placentas and maternal and neonatal blood (in a heavily polluted area) measured by graphite furnace atomic absorption spectrometry, Occup Environ Med, 52, 229, 10.1136/oem.52.4.229 · DOI
  12. Piasek, 2001, Placental cadmium and progesterone concentrations in cigarette smokers, Reprod Toxicol, 15, 673, 10.1016/S0890-6238(01)00174-5 · DOI
  13. Berlin, 1992, Birth weight of children and cadmium accumulation in placentas of female nickel–cadmium (long-life) battery workers, IARC Sci Publ, 257
  14. Khera, 1980, Placental and stillbirth tissue lead concentrations in occupationally exposed women, Br J Ind Med, 37, 394
  15. Zadorozhnaja, 2000, Concentrations of arsenic, cadmium, copper, lead, mercury, and zinc in human placentas from two cities in Ukraine, J Toxicol Environ Health A, 61, 255, 10.1080/00984100050136571 · DOI
  16. Iyengar, 2001, Human placenta as a ‘dual’ biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 3: toxic trace elements in placenta and placenta as a biomarker for these elements, Sci Total Environ, 280, 221, 10.1016/S0048-9697(01)00827-0 · DOI
  17. Kantola, 2004, Selenium in pregnancy: is selenium an active defective ion against environmental chemical stress?, Environ Res, 96, 51, 10.1016/j.envres.2004.03.003 · DOI
  18. Siddiqui, 2003, Persistent chlorinated pesticides and intra-uterine foetal growth retardation: a possible association, Int Arch Occup Environ Health, 76, 75, 10.1007/s00420-002-0393-6 · DOI
  19. Falcon, 2004, HCH and DDT residues in human placentas in Murcia (Spain), Toxicology, 195, 203, 10.1016/j.tox.2003.10.009 · DOI
  20. Choi, 2004, Toxicological characteristics of endocrine-disrupting chemicals: developmental toxicity, carcinogenicity, and mutagenicity, J Toxicol Environ Health B Crit Rev, 7, 1, 10.1080/10937400490253229 · DOI
  21. Johnson, 2000, Are pesticides really endocrine disruptors?, Wis Med J, 99, 34
  22. Andersen, 2002, Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro, Toxicol Appl Pharmacol, 179, 1, 10.1006/taap.2001.9347 · DOI
  23. Augustowska, 2003, Effects of dioxin (2,3,7,8-TCDD) and PCDDs/PCDFs congeners mixture on steroidogenesis in human placenta tissue culture, Endocr Regul, 37, 11
  24. Paakki, 2000, Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes, Placenta, 21, 241, 10.1053/plac.1999.0471 · DOI
  25. Paakki, 2000, Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro, Environ Health Perspect, 108, 141, 10.1289/ehp.00108141 · DOI
  26. Piasek, 2002, Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue, Int Arch Occup Environ Health, 75, S36, 10.1007/s00420-002-0351-3 · DOI
  27. Eisenmann, 1995, Cadmium and glutathione: effect on human placental thromboxane and prostacyclin production, Reprod Toxicol, 9, 41, 10.1016/0890-6238(94)00054-Z · DOI
  28. Boyce, 1975, Smoking, human placental lactogen and birth weight, Br J Obstet Gynaecol, 82, 964, 10.1111/j.1471-0528.1975.tb00606.x · DOI
  29. Mochizuki, 1984, Effects of smoking on fetoplacental–maternal system during pregnancy, Am J Obstet Gynecol, 149, 413, 10.1016/0002-9378(84)90156-X · DOI · Paper page
  30. Bernstein, 1989, Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels, Br J Obstet Gynaecol, 96, 92, 10.1111/j.1471-0528.1989.tb01582.x · DOI
  31. Plessinger, 1999, Effects of zidovudine (AZT) and dideoxyinosine (ddI) on human trophoblast cells, Reprod Toxicol, 13, 537, 10.1016/S0890-6238(99)00052-0 · DOI
  32. Moore, 1988, Polyamines control human chorionic gonadotropin production in the JEG-3 choriocarcinoma cell, J Biol Chem, 263, 12765, 10.1016/S0021-9258(18)37819-0 · DOI
  33. Chou, 1978, Regulation of the synthesis of human chorionic gonadotrophin by 5-bromo-2′-deoxyuridine and dibutyryl cyclic AMP in trophoblastic and nontrophoblastic tumor cells, J Clin Endocrinol Metab, 47, 46, 10.1210/jcem-47-1-46 · DOI
  34. Hussa, 1975, Regulation of human chorionic gonadotropin (hCG) secretion by serum and dibutyryl cyclic AMP in malignant trophoblast cells in vitro, J Clin Endocrinol Metab, 40, 401, 10.1210/jcem-40-3-401 · DOI
  35. Sibley, 1991, Bromo-adenosine stimulates choriogonadotropin production in JAr and cytotrophoblast cells: evidence for effects on two stages of differentiation, Mol Endocrinol, 5, 582, 10.1210/mend-5-4-582 · DOI
  36. Guo, 1999, Endocrine biomarkers of early fetal loss in cynomolgus macaques (Macaca fascicularis) following exposure to dioxin, Biol Reprod, 60, 707, 10.1095/biolreprod60.3.707 · DOI
  37. Chen, 2003, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on chorionic gonadotropin secretion by human trophoblasts, Reprod Toxicol, 17, 87, 10.1016/S0890-6238(02)00077-1 · DOI
  38. Ng, 2003, From the cover: mRNA of placental origin is readily detectable in maternal plasma, Proc Natl Acad Sci USA, 100, 4748, 10.1073/pnas.0637450100 · DOI
  39. Krishna, 1994, Extrahepatic metabolism of drugs in humans, Clin Pharmacokinet, 26, 144, 10.2165/00003088-199426020-00007 · DOI
  40. Baron, 2001, Drug metabolism in the skin, Curr Opin Allergy Clin Immunol, 1, 287, 10.1097/01.all.0000011028.08297.b3 · DOI
  41. Doherty, 2002, The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?, Clin Pharmacokinet, 41, 235, 10.2165/00003088-200241040-00001 · DOI
  42. Welch, 1968, Cigarette smoking: stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta, Science, 160, 541, 10.1126/science.160.3827.541 · DOI
  43. Namkung, 1980, On the capacity of human placental enzymes to catalyze the formation of diols from benzo[a]pyrene, Toxicol Appl Pharmacol, 55, 253, 10.1016/0041-008X(80)90087-3 · DOI
  44. Vähäkangas, 1989, Comparison of the formation of benzo[a]pyrene diolepoxide–DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2, J Biochem Toxicol, 4, 79, 10.1002/jbt.2570040203 · DOI
  45. Hansen, 1993, Detection of carcinogen–DNA adducts in human fetal tissues by the 32P-postlabeling procedure, Environ Health Perspect, 99, 229
  46. Hakkola, 1996, Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy, Biochem Pharmacol, 52, 379, 10.1016/0006-2952(96)00216-X · DOI
  47. Hakkola, 1996, Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta, Biochem Pharmacol, 51, 403, 10.1016/0006-2952(95)02184-1 · DOI
  48. Hakkola, 1998, Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity, Crit Rev Toxicol, 28, 35, 10.1080/10408449891344173 · DOI · Paper page
  49. Pasanen, 1999, The expression and regulation of drug metabolism in human placenta, Adv Drug Deliv Rev, 38, 81, 10.1016/S0169-409X(99)00008-3 · DOI
  50. Karl, 1988, Acetaldehyde production and transfer by the perfused human placental cotyledon, Science, 242, 273, 10.1126/science.3175652 · DOI
  51. Smelt, 2000, Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos, Hum Mol Genet, 9, 1101, 10.1093/hmg/9.7.1101 · DOI
  52. Collier, 2000, A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines, Drug Metab Dispos, 28, 1184, 10.1016/S0026-895X(24)12047-0 · DOI
  53. Collier, 2002, Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption, Hum Reprod, 17, 2564, 10.1093/humrep/17.10.2564 · DOI
  54. Collier, 2002, UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term, Biochem Pharmacol, 63, 409, 10.1016/S0006-2952(01)00890-5 · DOI
  55. Stanley, 2001, Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development, J Clin Endocrinol Metab, 86, 5944, 10.1210/jcem.86.12.8081 · DOI
  56. Schenker, 1999, Olanzapine transfer by human placenta, Clin Exp Pharmacol Physiol, 26, 691, 10.1046/j.1440-1681.1999.03111.x · DOI
  57. Pasanen, 1990, Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities, Toxicology, 62, 175, 10.1016/0300-483X(90)90108-S · DOI
  58. Lagueux, 1999, Cytochrome P450 CYP1A1 enzyme activity and DNA adducts in placenta of women environmentally exposed to organochlorines, Environ Res, 80, 369, 10.1006/enrs.1998.3920 · DOI
  59. Pasanen, 1997, Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro, Placenta, 18, 37, 10.1016/S0143-4004(97)90069-2 · DOI
  60. Collier, 2003, 3′-azido-3′-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta, Toxicol Appl Pharmacol, 192, 164, 10.1016/S0041-008X(03)00274-6 · DOI
  61. Pelkonen, 1973, Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers, Arch Int Pharmacodyn Ther, 202, 288
  62. Everson, 1986, Detection of smoking-related covalent DNA adducts in human placenta, Science, 231, 54, 10.1126/science.3941892 · DOI
  63. Carlberg, 2000, DNA adducts in human placenta as biomarkers for environmental pollution, analysed by the 32P-HPLC method, Biomarkers, 5, 182, 10.1080/135475000230343 · DOI
  64. Marafie, 2000, Biomonitoring the human population exposed to pollution from the oil fires in Kuwait: analysis of placental tissue using (32)P-postlabeling, Environ Mol Mutagen, 36, 274, 10.1002/1098-2280(2000)36:4<274::AID-EM3>3.0.CO;2-D · DOI
  65. Hansen, 1993, Detection of carcinogen–DNA adducts in human fetal tissues by the 32P-postlabeling procedure, Environ Health Perspect, 99, 229
  66. Perera, 1998, Recent developments in molecular epidemiology: a study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland, Am J Epidemiol, 147, 309, 10.1093/oxfordjournals.aje.a009451 · DOI
  67. Perera, 2002, In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns, Cancer Epidemiol Biomarkers Prev, 11, 1134
  68. Everson, 1988, Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight, J Natl Cancer Inst, 80, 567, 10.1093/jnci/80.8.567 · DOI
  69. Topinka, 1997, Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population, Environ Mol Mutagen, 30, 184, 10.1002/(SICI)1098-2280(1997)30:2<184::AID-EM11>3.0.CO;2-9 · DOI
  70. Topinka, 1997, DNA adducts in human placenta as related to air pollution and to GSTM1 genotype, Mutat Res, 390, 59, 10.1016/S0165-1218(96)00166-8 · DOI
  71. Wang, 2002, Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight, JAMA, 287, 195, 10.1001/jama.287.2.195 · DOI
  72. Obolenskaya, 1997, Glutathione status of placentae from differently polluted regions of Ukraine, Eur J Obstet Gynecol Reprod Biol, 71, 23, 10.1016/S0301-2115(96)02611-5 · DOI
  73. McBride, 1961, Thalidomide and congenital abnormalities, Lancet, 278, 1358, 10.1016/S0140-6736(61)90927-8 · DOI · Paper page
  74. Koren, 1998, Drugs in pregnancy, N Engl J Med, 338, 1128, 10.1056/NEJM199804163381607 · DOI
  75. Webster, 2001, Is this drug safe in pregnancy?, Reprod Toxicol, 15, 619, 10.1016/S0890-6238(01)00185-X · DOI
  76. Waalkes, 2003, Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice, Toxicol Appl Pharmacol, 186, 7, 10.1016/S0041-008X(02)00022-4 · DOI
  77. Diwan, 1999, Multiorgan transplacental and neonatal carcinogenicity of 3′-azido-3′-deoxythymidine in mice, Toxicol Appl Pharmacol, 161, 82, 10.1006/taap.1999.8782 · DOI
  78. Newbold, 1996, Transplacental hormonal carcinogenesis: diethylstilbestrol as an example, Prog Clin Biol Res, 394, 131
  79. Moore, 2003, The epidemiology of neonatal tumours. Report of an international working group, Pediatr Surg Int, 19, 509, 10.1007/s00383-003-1048-8 · DOI
  80. Satge, 1998, Antenatal therapeutic drug exposure and fetal/neonatal tumours: review of 89 cases, Paediatr Perinat Epidemiol, 12, 84, 10.1111/j.1365-3016.1998.00080.x · DOI
  81. Reynolds, 1989, Pharmacokinetics in pregnancy and placental drug transfer, Oxf Rev Reprod Biol, 11, 389
  82. Pacifici, 1995, Placental transfer of drugs administered to the mother, Clin Pharmacokinet, 28, 235, 10.2165/00003088-199528030-00005 · DOI
  83. King, 2000, Cell culture models of trophoblast II: trophoblast cell lines—a workshop report, Placenta, 21, S113, 10.1053/plac.1999.0526 · DOI
  84. St Pierre, 2002, Mechanisms of drug transfer across the human placenta—a workshop report, Placenta, 23, S159, 10.1053/plac.2002.0821 · DOI
  85. Bloxam, 1997, Culture of syncytiotrophoblast for the study of human placental transfer. Part I: isolation and purification of cytotrophoblast, Placenta, 18, 93, 10.1016/S0143-4004(97)90079-5 · DOI
  86. Bloxam, 1997, Culture of syncytiotrophoblast for the study of human placental transfer. Part II: production, culture and use of syncytiotrophoblast, Placenta, 18, 99, 10.1016/S0143-4004(97)90080-1 · DOI
  87. Sastry, 1999, Techniques to study human placental transport, Adv Drug Deliv Rev, 38, 17, 10.1016/S0169-409X(99)00004-6 · DOI
  88. Bourget, 1995, Models for placental transfer studies of drugs, Clin Pharmacokinet, 28, 161, 10.2165/00003088-199528020-00006 · DOI
  89. Maguire, 1999, In vitro placental perfusion. Practical parameters and procedural performance, Adv Exp Med Biol, 471, 361, 10.1007/978-1-4615-4717-4_43 · DOI
  90. Ganapathy, 2000, Placental transporters relevant to drug distribution across the maternal–fetal interface, J Pharmacol Exp Ther, 294, 413, 10.1016/S0022-3565(24)39087-1 · DOI
  91. Knipp, 1999, Nutrient transport across the placenta, Adv Drug Deliv Rev, 38, 41, 10.1016/S0169-409X(99)00005-8 · DOI
  92. Young, 2003, Efflux transporters of the human placenta, Adv Drug Deliv Rev, 55, 125, 10.1016/S0169-409X(02)00174-6 · DOI
  93. Ugele, 2003, Characterization and identification of steroid sulfate transporters of human placenta, Am J Physiol Endocrinol Metab, 284, E390, 10.1152/ajpendo.00257.2002 · DOI
  94. St Pierre, 2002, Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta, J Clin Endocrinol Metab, 87, 1856, 10.1210/jcem.87.4.8431 · DOI
  95. Unadkat, 2004, Placental drug transporters, Curr Drug Metab, 5, 125, 10.2174/1389200043489171 · DOI
  96. Tanabe, 2001, Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene, J Pharmacol Exp Ther, 297, 1137, 10.1016/S0022-3565(24)29643-9 · DOI
  97. Smit, 1999, Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure, J Clin Invest, 104, 1441, 10.1172/JCI7963 · DOI
  98. Lankas, 1998, Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice, Reprod Toxicol, 12, 457, 10.1016/S0890-6238(98)00027-6 · DOI
  99. Pascolo, 2003, Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells, Biochem Biophys Res Commun, 303, 259, 10.1016/S0006-291X(03)00327-9 · DOI
  100. St Pierre, 2000, Expression of members of the multidrug resistance protein family in human term placenta, Am J Physiol Regul Integr Comp Physiol, 279, R1495, 10.1152/ajpregu.2000.279.4.R1495 · DOI
  101. Pascolo, 2001, Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells, FEBS Lett, 495, 94, 10.1016/S0014-5793(01)02357-2 · DOI
  102. Jonker, 2000, Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan, J Natl Cancer Inst, 92, 1651, 10.1093/jnci/92.20.1651 · DOI
  103. Ritchie, 2001, Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta, Biochem J, 356, 719, 10.1042/bj3560719 · DOI
  104. Uchino, 2002, Transport of amino acid-related compounds mediated by l-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition, Mol Pharmacol, 61, 729, 10.1016/S0026-895X(24)12322-X · DOI
  105. Ganapathy, 1999, Drugs of abuse and placental transport, Adv Drug Deliv Rev, 38, 99, 10.1016/S0169-409X(99)00009-5 · DOI
  106. Pastrakuljic, 2000, The effects of cocaine and nicotine on amino acid transport across the human placental cotyledon perfused in vitro, J Pharmacol Exp Ther, 294, 141, 10.1016/S0022-3565(24)39049-4 · DOI
  107. Pastrakuljic, 1999, Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth, Placenta, 20, 499, 10.1053/plac.1999.0418 · DOI
  108. Haggarty, 2002, The effect of maternal smoking and ethanol on fatty acid transport by the human placenta, Br J Nutr, 87, 247, 10.1079/BJN2001514 · DOI
  109. Kajiwara, 1996, Methylmercury transport across the placenta via neutral amino acid carrier, Arch Toxicol, 70, 310, 10.1007/s002040050279 · DOI
  110. Rice, 1986, The effect of ethanol on the production of lactate, triglycerides, phospholipids, and free fatty acids in the perfused human placenta, Am J Obstet Gynecol, 155, 207, 10.1016/0002-9378(86)90112-2 · DOI
  111. Taylor, 1994, Pressor effect of ethanol in the isolated perfused human placental lobule, Eur J Pharmacol, 270, 371
  112. Rothenberg, 2004, Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect, N Engl J Med, 350, 134, 10.1056/NEJMoa031145 · DOI
  113. da Costa, 2003, Antibodies to folate receptors impair embryogenesis and fetal development in the rat, Birth Defects Res Part A Clin Mol Teratol, 67, 837, 10.1002/bdra.10088 · DOI
  114. Faber, 2003, Drug transport proteins in the liver, Adv Drug Deliv Rev, 55, 107, 10.1016/S0169-409X(02)00173-4 · DOI
  115. Fromm, 2002, The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans, Adv Drug Deliv Rev, 54, 1295, 10.1016/S0169-409X(02)00064-9 · DOI
  116. Jacquemin, 1999, Genetic basis of progressive familial intrahepatic cholestasis, J Hepatol, 31, 377, 10.1016/S0168-8278(99)80240-2 · DOI
  117. Jacquemin, 2001, The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood, Gastroenterology, 120, 1448, 10.1053/gast.2001.23984 · DOI
  118. Wang, 2002, The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II, J Clin Invest, 110, 965, 10.1172/JCI0215968 · DOI
  119. Azzaroli, 2004, MRP2 is upregulated by UDCA in cholestasis of pregnancy, J Hepatol, 40, 4, 10.1016/S0168-8278(04)90005-0 · DOI
  120. Serrano, 2003, Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta–maternal liver tandem excretory pathway, J Pharmacol Exp Ther, 305, 515, 10.1124/jpet.102.047977 · DOI
  121. Morris, 1998, Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia, Br J Obstet Gynaecol, 105, 1195, 10.1111/j.1471-0528.1998.tb09974.x · DOI
  122. Iioka, 1991, Changes in plasma levels of lipid peroxide and vitamin E during pregnancy, Asia Oceania J Obstet Gynaecol, 17, 357, 10.1111/j.1447-0756.1991.tb00286.x · DOI
  123. Maseki, 1981, Lipid peroxide levels and lipids content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia, Clin Chim Acta, 115, 155, 10.1016/0009-8981(81)90071-1 · DOI
  124. Coughlan, 2004, Altered placental oxidative stress status in gestational diabetes mellitus, Placenta, 25, 78, 10.1016/S0143-4004(03)00183-8 · DOI
  125. Hass, 2003, Increased oxidative stress in pre-eclamptic placenta is associated with altered proteasome activity and protein patterns, Placenta, 24, 979, 10.1016/S0143-4004(03)00174-7 · DOI
  126. Shibata, 2003, Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae, Placenta, 24, 698, 10.1016/S0143-4004(03)00083-3 · DOI
  127. Sikkema, 2001, Placental superoxide is increased in pre-eclampsia, Placenta, 22, 304, 10.1053/plac.2001.0629 · DOI
  128. Ishimura, 2002, Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats, Toxicol Appl Pharmacol, 185, 197, 10.1006/taap.2002.9539 · DOI
  129. Tabacova, 1994, Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal–infant pairs from a copper smelter area, Placenta, 15, 873, 10.1016/S0143-4004(05)80188-2 · DOI
  130. Kay, 2000, Ethanol exposure induces oxidative stress and impairs nitric oxide availability in the human placental villi: a possible mechanism of toxicity, Am J Obstet Gynecol, 182, 682, 10.1067/mob.2000.104201 · DOI
  131. Hassoun, 1997, Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid, Toxicology, 124, 27, 10.1016/S0300-483X(97)00127-3 · DOI
  132. Genbacev, 1997, Regulation of humanplacental development by oxygen tension, Science, 277, 1669, 10.1126/science.277.5332.1669 · DOI
  133. Genbacev, 2003, Disruption of oxygen-regulated responses underlies pathological changes in the placentas of women who smoke or who are passively exposed to smoke during pregnancy, Reprod Toxicol, 17, 509, 10.1016/S0890-6238(03)00094-7 · DOI
  134. Kulakov, 1993, Female reproductive function in areas affected by radiation after the Chernobyl power station accident, Environ Health Perspect, 101, 117, 10.1289/ehp.93101s2117 · DOI
  135. Tenchini, 1983, A comparative cytogenetic study on cases of induced abortions in TCDD-exposed and nonexposed women, Environ Mutagen, 5, 73, 10.1002/em.2860050109 · DOI
  136. Remotti, 1981, The morphology of early trophoblast after dioxin poisoning in the Seveso area, Placenta, 2, 53, 10.1016/S0143-4004(81)80040-9 · DOI
  137. Little, 2003, Placental weight and its ratio to birthweight in a Ukrainian city, Early Hum Dev, 71, 117, 10.1016/S0378-3782(02)00118-4 · DOI
  138. Ray, 1986, Bovine abortion and death associated with consumption of aflatoxin-contaminated peanuts, J Am Vet Med Assoc, 188, 1187, 10.2460/javma.1986.188.10.1187 · DOI
  139. Amin, 2002, Genomic interrogation of mechanism(s) underlying cellular responses to toxicants, Toxicology, 181–182, 555, 10.1016/S0300-483X(02)00481-X · DOI
  140. Bilban, 2000, DNA microarrays: a novel approach to investigate genomics in trophoblast invasion—a review, Placenta, 21, S99, 10.1053/plac.1999.0517 · DOI
  141. Kim, 2002, Drugs as P-glycoprotein substrates, inhibitors, and inducers, Drug Metab Rev, 34, 47, 10.1081/DMR-120001389 · DOI
  142. Avery, 2003, The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line, Placenta, 24, 45, 10.1053/plac.2002.0876 · DOI
  143. Ushigome, 2000, Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein, Eur J Pharmacol, 408, 1, 10.1016/S0014-2999(00)00743-3 · DOI
  144. Nagashige, 2003, Basal membrane localization of MRP1 in human placental trophoblast, Placenta, 24, 951, 10.1016/S0143-4004(03)00170-X · DOI

Cited by

See all 225

Metadata

Authors
Myllynen, P., Pasanen, M., & Pelkonen, O.
Venue
Placenta
Publisher
Elsevier BV
Published
2005-05
Volume
26
Issue
5
Pages
361-371
ISSN
0143-4004
DOI
10.1016/j.placenta.2004.09.006
Cited by
225
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.